Cargando…
Use of methylphenidate in alzheimer’s dementia: Effect on apathy
INTRODUCTION: Alzheimer’s Disease (AD) is associated with neuropsychiatric symptoms such as agitation depression and apathy. It has been proposed that the pathophysiology of apathy, that is defined as quantitative reduction in goal-directed activity compared with previous functioning, in AD is assoc...
Autores principales: | Borralho, R., Oliveira, C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9475565/ http://dx.doi.org/10.1192/j.eurpsy.2021.1135 |
Ejemplares similares
-
Neurobiologic Rationale for Treatment of Apathy in Alzheimer’s Disease With Methylphenidate
por: van Dyck, Christopher H., et al.
Publicado: (2020) -
PAIN IN PERSONS WITH DEMENTIA AND APATHY IN NURSING HOMES
por: Liao, Yo-Jen, et al.
Publicado: (2022) -
The use of methylphenidate in vascular dementia: A case report
por: Regueira, P., et al.
Publicado: (2021) -
The Apathy in Dementia Methylphenidate Trial 2 (ADMET 2): study protocol for a randomized controlled trial
por: Scherer, Roberta W., et al.
Publicado: (2018) -
Barriers to and Facilitators for Optimal Intervention for Apathy in Older Adults With Dementia
por: Agboji, Aderonke, et al.
Publicado: (2021)